Anti-LIMA1 antibodies are used in the immunodetection of the protein LIM domain and actin binding 1. In humans, the canonical protein has a reported length of 759 amino acid residues and a mass of 85.2 kDa. Its subcellular localization is in the cell membrane and cytoplasm. Up to 5 different isoforms have been reported for this protein. It is reported to be highly expressed in the placenta, kidney, pancreas, prostate, ovary, spleen and heart. LIMA1 is known to be an actin-binding protein involved in actin cytoskeleton regulation and dynamics. Post-translational modifications have been described, including phosphorylation. Synonyms for this target antigen include LDLCQ8, SREBP3, LIM domain and actin-binding protein 1, epithelial protein lost in neoplasm beta, sterol regulatory element binding protein 3, and EPLIN. LIMA1 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of LIMA1 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. In addition, Immunohistochemistry is also a common application.